Modulation of regional nitric oxide metabolism: Blood glucose control or insulin? (Intensive Care Medicine (2008) DOI: 10.1007/s00134-008-1118-4);Modulation of regional nitric oxide metabolism: Blood glucose control or insulin?

Intensive Care Medicine

Volumn 34, Issue 8, 2008, Pages 1525-1533

  Ellger, Björn ^a,b   Langouche, Lies ^a   Richir, Milan ^c   Debaveye, Yves ^a   Vanhorebeek, Ilse ^a   Van Leeuwen, Paul A ^c   Van Den Berghe, Greet ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Endothelium; Glucose; Insulin; Intensive insulin therapy; Nitric oxide; Nitric oxide synthase

Indexed keywords

ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; ISOENZYME; N(G),N(G) DIMETHYLARGININE; NEUTRAL INSULIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; BLOOD GLUCOSE MONITORING; BLOOD VESSEL BIOPSY; CELL DAMAGE; CONTINUOUS INFUSION; CONTROLLED STUDY; CRITICAL ILLNESS; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXPERIMENTAL MODEL; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN TREATMENT; LIVER BIOPSY; MALE; METABOLISM; MUSCLE BIOPSY; NONHUMAN; PROSPECTIVE STUDY; RABBIT; VASCULAR RING;

EID: 48149097884     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-008-1162-0     Document Type: Erratum

References (37)

1. SA Nasraway Jr 2006 Hyperglycemia during critical illness J Parenter Enteral Nutr 30 254 258
2. G Van den Berghe P Wouters F Weekers C Verwaest F Bruyninckx M Schetz D Vlasselaers P Ferdinande P Lauwers R Bouillon 2001 Intensive insulin therapy in critically ill patients N Engl J Med 345 1359 1367
3. AG Pittas RD Siegel J Lau 2006 Insulin therapy and in-hospital mortality in critically ill patients: systematic review and meta-analysis of randomized controlled trials J Parenter Enteral Nutr 30 164 172
4. G Van den Berghe A Wilmer G Hermans W Meersseman PJ Wouters I Milants E Van Wijngaerden H Bobbaers R Bouillon 2006 Intensive insulin therapy in the medical ICU N Engl J Med 354 449 461
5. G Van den Berghe 2004 How does blood glucose control with insulin save lives in intensive care? J Clin Invest 114 1187 1195
6. L Langouche I Vanhorebeek D Vlasselaers S Vander Perre PJ Wouters K Skogstrand TK Hansen G Van den Berghe 2005 Intensive insulin therapy protects the endothelium of critically ill patients J Clin Invest 115 2277 2286
7. B Ellger Y Debaveye I Vanhorebeek L Langouche A Giulietti E Van Etten P Herijgers C Mathieu G Van den Berghe 2006 Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin Diabetes 55 1096 1105
8. MP Siroen PA van Leeuwen RJ Nijveldt T Teerlink PJ Wouters G Van den Berghe 2005 Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: A possible explanation of reduced morbidity and mortality? Crit Care Med 33 504 510
9. H Li T Wallerath U Forstermann 2002 Physiological mechanisms regulating the expression of endothelial-type NO synthase Nitric Oxide 7 132 147
10. MM Hallemeesch BJ Janssen WJ de Jonge PB Soeters WH Lamers NE Deutz 2003 NO production by cNOS and iNOS reflects blood pressure changes in LPS-challenged mice Am J Physiol Endocrinol Metab 285 E871 E875
11. K Kuboki ZY Jiang N Takahara SW Ha M Igarashi T Yamauchi EP Feener TP Herbert CJ Rhodes GL King 2000 Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin Circulation 101 676 681
12. F Aktan 2004 iNOS-mediated nitric oxide production and its regulation Life Sci 75 639 653
13. A Rawlingson 2003 Nitric oxide, inflammation and acute burn injury Burns 29 631 640
14. A Lopez JA Lorente J Steingrub J Bakker A McLuckie S Willatts M Brockway A Anzueto L Holzapfel D Breen MS Silverman J Takala J Donaldson C Arneson G Grove S Grossman R Grover 2004 Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock Crit Care Med 32 21 30
15. MP Siroen T Teerlink RJ Nijveldt HA Prins MC Richir PA van Leeuwen 2006 The clinical significance of asymmetric dimethylarginine Annu Rev Nutr 26 203 228
16. D Tsikas RH Boger J Sandmann SM Bode-Boger JC Frolich 2000 Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox FEBS Lett 478 1 3
17. Ellger B, Richir MC, Langouche L, van Leeuwen PA, Van den Berghe G (2007) Normoglycemia and not glycemia-independent actions of insulin maintain physiologic NOS-activity by preserving physiological regulation of ADMA-levels. EJA 24 edn, p S40
18. Ellger B, Richir MC, Langouche L, Debaveye Y, Vanhorebeek I, van Leeuwen PA, Van den Berghe G (2007) Endothelial dysfunction in critical illness: Glycemic control or glycemia independent actions of insulin? EJA 32[S1] edn, p S273
19. BL Nyomba R Bouillon P De Moor 1984 Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit Endocrinology 115 191 197
20. D Brealey M Brand I Hargreaves S Heales J Land R Smolenski NA Davies CE Cooper M Singer 2002 Association between mitochondrial dysfunction and severity and outcome of septic shock Lancet 360 219 223
21. W Laleman A Omasta M Van de Casteele M Zeegers I Vander Elst L Van Landeghem T Severi J van Pelt T Roskams J Fevery F Nevens 2005 A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis Hepatology 42 1382 1390
22. Y Hattori SS Gross 1993 GTP cyclohydrolase I mRNA is induced by LPS in vascular smooth muscle: characterization, sequence and relationship to nitric oxide synthase Biochem Biophys Res Commun 195 435 441
23. T Teerlink RJ Nijveldt S de Jong PA van Leeuwen 2002 Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography Anal Biochem 303 131 137
24. D Taubert A Rosenkranz R Berkels R Roesen E Schomig 2004 Acute effects of glucose and insulin on vascular endothelium Diabetologia 47 2059 2071
25. AM Kahn JC Allen CL Seidel DS Lichtenberg T Song S Zhang 2000 Insulin increases NO-stimulated guanylate cyclase activity in cultured VSMC while raising redox potential Am J Physiol Endocrinol Metab 278 E627 E633
26. G Kroder B Bossenmaier M Kellerer E Capp B Stoyanov A Muhlhofer L Berti H Horikoshi A Ullrich H Haring 1996 Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling J Clin Invest 97 1471 1477
27. M Federici R Menghini A Mauriello ML Hribal F Ferrelli D Lauro P Sbraccia LG Spagnoli G Sesti R Lauro 2002 Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells Circulation 106 466 472
28. S Liu IM Adcock RW Old PJ Barnes TW Evans 1993 Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA Biochem Biophys Res Commun 196 1208 1213
29. L Ste-Marie AS Hazell C Bemeur R Butterworth J Montgomery 2001 Immunohistochemical detection of inducible nitric oxide synthase, nitrotyrosine and manganese superoxide dismutase following hyperglycemic focal cerebral ischemia Brain Res 918 10 19
30. K Stockklauser-Farber T Ballhausen A Laufer P Rosen 2000 Influence of diabetes on cardiac nitric oxide synthase expression and activity Biochim Biophys Acta 1535 10 20
31. J Jimenez-Feltstrom I Lundquist A Salehi 2005 Glucose stimulates the expression and activities of nitric oxide synthases in incubated rat islets: an effect counteracted by GLP-1 through the cyclic AMP/PKA pathway Cell Tissue Res 319 221 230
32. TK Hansen S Thiel PJ Wouters JS Christiansen G Van den Berghe 2003 Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels J Clin Endocrinol Metab 88 1082 1088
33. JM Griscavage AJ Hobbs LJ Ignarro 1995 Negative modulation of nitric oxide synthase by nitric oxide and nitroso compounds Adv Pharmacol 34 215 234
34. J Lee H Ryu RJ Ferrante SM Morris Jr RR Ratan 2003 Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox Proc Natl Acad Sci USA 100 4843 4848
35. MC Stuhlinger F Abbasi JW Chu C Lamendola TL McLaughlin JP Cooke GM Reaven PS Tsao 2002 Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor J Am Med Assoc 287 1420 1426
36. V Sorrenti F Mazza A Campisi L Vanella VG Li GC Di 2006 High glucose-mediated imbalance of nitric oxide synthase and dimethylarginine dimethylaminohydrolase expression in endothelial cells Curr Neurovasc Res 3 49 54
37. H Miyazaki H Matsuoka JP Cooke M Usui S Ueda S Okuda T Imaizumi 1999 Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis Circulation 99 1141 1146